Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Anderer, P' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 73 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rappelsberger, P; Trenker, E; Rothmann, C; Gruber, G; Sykacek, P; Roberts, S; Klosch, G; Zeitlhofer, J; Anderer, P; Saletu, B; Schlogl, A; Varri, A; Kemp, B; Penzel, T; Herrmann, W; Hasan, J; Barbanoj, MJ; Kunz, D; Dorffner, G
      The SIESTA project

      KLINISCHE NEUROPHYSIOLOGIE
    2. Saletu, M; Anderer, P; Saletu-Zyhlarz, G; Prause, W; Semler, B; Zoghlami, A; Gruber, G; Hauer, C; Saletu, B
      Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) - Acute placebo-controlled sleep laboratory studies with clonazepam

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    3. Hofer, E; Doby, D; Anderer, P; Dantendorfer, K
      Impaired conditional discrimination learning in schizophrenia

      SCHIZOPHRENIA RESEARCH
    4. Saletu, M; Anderer, P; Saletu, B; Hauer, C; Mandl, M; Semler, B; Saletu-Zyhlarz, G
      Sleep laboratory studies in periodic limb movement disorder (PLMD) patients as compared with normals and acute effects of ropinirole

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    5. Anderer, P; Klosch, G; Gruber, G; Trenker, E; Pascual-Marqui, RD; Zeitlhofer, J; Barbanoj, MJ; Rappelsberger, P; Saletu, B
      Low-resolution brain electromagnetic tomography revealed simultaneously active frontal and parietal sleep spindle sources in the human cortex

      NEUROSCIENCE
    6. Saletu-Zyhlarz, GM; Abu-Bakr, MH; Anderer, P; Semler, B; Decker, K; Parapatics, S; Tschida, U; Winkler, A; Saletu, B
      Insomnia related to dysthymia: Polysomnographic and psychometric comparison with normal controls and acute therapeutic trials with trazodone

      NEUROPSYCHOBIOLOGY
    7. Mayerhofer, K; Bodner, K; Saletu, B; Bodner-Adler, B; Anderer, P; Hefler, L; Schindl, M; Kaider, A; Leodolter, S; Kainz, C
      Paclitaxel-carboplatin chemotherapy does not cause encephalopathy in patients with ovarian cancer: A prospective EEG mapping study in 28 patients

      ANTICANCER RESEARCH
    8. Saletu, B; Anderer, P; Saletu-Zyhlarz, GM
      Nonorganic hypersomnia - Epidemiology, diagnosis and treatment

      WIENER KLINISCHE WOCHENSCHRIFT
    9. Klosch, G; Gruber, G; Anderer, P; Saletu, B
      Activity monitoring in sleep research, medicine and psychopharmacology

      WIENER KLINISCHE WOCHENSCHRIFT
    10. Saletu, B; Anderer, P; Gruber, G; Mandl, M; Gruber, D; Metka, M; Huber, J; Loffler, H; Abu-Bakr, MH; Saletu-Zyhlarz, GM
      Insomnia related to postmenopausal syndrome: Sleep laboratory studies on differences between patients and normal controls, and influence of an estrogen-progestogen combination with dienogest versus estrogen alone and placebo

      DRUGS OF TODAY
    11. Gutierrez-Lobos, K; Wolfl, G; Scherer, M; Anderer, P; Schmidl-Mohl, B
      The gender gap in depression reconsidered: the influence of marital and employment status on the female/male ratio of treated incidence rates

      SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
    12. Anderer, P; Saletu, B; Pascual-Marqui, RD
      Effect of the 5-HT1A partial agonist buspirone on regional brain electrical activity in man: a functional neuroimaging study using low-resolution electromagnetic tomography (LORETA)

      PSYCHIATRY RESEARCH-NEUROIMAGING
    13. Oberndorfer, S; Saletu, B; Gruber, G; Anderer, P; Saletu, M; Mandl, M; Saletu-Zyhlarz, G
      Theophylline in snoring and sleep-related breathing disorders: Sleep laboratory investigations on subjective and objective sleep and awakening quality

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    14. Howorka, K; Pumprla, J; Saletu, B; Anderer, P; Krieger, M; Schabmann, A
      Decrease of vigilance assessed by EEG-mapping in Type I diabetic patients with history of recurrent severe hypoglycaemia

      PSYCHONEUROENDOCRINOLOGY
    15. Saletu, M; Anderer, P; Saletu, B; Hauer, C; Mandl, M; Oberndorfer, S; Zoghlami, A; Saletu-Zyhlarz, G
      Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole 2. Findings on periodic leg movement, arousals and respiratory variables

      NEUROPSYCHOBIOLOGY
    16. Saletu-Zyhlarz, G; Anderer, P; Brandstatter, N; Dantendorfer, K; Gruber, G; Mandl, M; Ritter, K; Zoghlami, A; Saletu, B
      Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder

      NEUROPSYCHOBIOLOGY
    17. Anderer, P
      Chaos and order in the works of natsume Soseki.

      JOURNAL OF JAPANESE STUDIES
    18. Saletu, M; Hauer, C; Anderer, P; Saletu-Zyhlarz, G; Gruber, G; Oberndorfer, S; Mandl, M; Popovic, R; Saletu, B
      Daytime tiredness correlates with nocturnal respiratory and arousal variables in sleep apnea patients: Polysomnography and EEG mapping investigations

      WIENER KLINISCHE WOCHENSCHRIFT
    19. Mayerhofer, K; Bodner, K; Saletu, B; Bodner-Adler, B; Anderer, P; Hefler, L; Kaider, A; Leodolter, S; Kainz, C
      Paclitaxel does not cause central nervous adverse effects: A prospective vigilance-controlled EEG mapping study in ovarian cancer patients

      WIENER KLINISCHE WOCHENSCHRIFT
    20. Anderer, P; Roberts, S; Schlogl, A; Gruber, G; Klosch, G; Herrmann, W; Rappelsberger, P; Filz, O; Barbanoj, MJ; Dorffner, G; Saletu, B
      Artifact processing in computerized analysis of sleep EEG - A review

      NEUROPSYCHOBIOLOGY
    21. Saletu, B; Oberndorfer, S; Anderer, P; Gruber, G; Divos, H; Lachner, A; Mandl, M; Parapatics, S; Popp, W; Salet, M; Saletu-Zyhlarz, G; Sertl, K; Strobl, R; Tschida, U; Winkler, A
      Efficiency of continuous positive airway pressure versus theophylline therapy in sleep apnea: Comparative sleep laboratory studies on objective and subjective sleep and awakening quality

      NEUROPSYCHOBIOLOGY
    22. Anderer, P
      Studies in the comic spirit in modern Japanese fiction

      HARVARD JOURNAL OF ASIATIC STUDIES
    23. MAIERHOFER D; ANDERER P; DANTENDORFER K
      IMPAIRED CONDITIONAL DISCRIMINATION IN PANIC DISORDER PATIENTS

      European journal of neuroscience
    24. MARGREITERNEUWIRTH N; EBERSTALLER M; HOFER E; ANDERER P; NEUWIRTH W; SEMLITSCH HV; DANTENDORFER K
      TEMPORAL-LOBE FUNCTION AND CONDITIONAL DISCRIMINATION-LEARNING IN SCHIZOPHRENIA

      Schizophrenia research
    25. ANDERER P; PASCUALMARQUI RD; SEMLITSCH HV; SALETU B
      ELECTRICAL SOURCES OF P300 EVENT-RELATED BRAIN POTENTIALS REVEALED BYLOW-RESOLUTION ELECTROMAGNETIC TOMOGRAPHY .1. EFFECTS OF NORMAL AGING

      Neuropsychobiology
    26. ANDERER P; SALETU B; SEMLITSCH HV; PASCUALMARQUI RD
      ELECTRICAL SOURCES OF P300 EVENT-RELATED BRAIN POTENTIALS REVEALED BYLOW-RESOLUTION ELECTROMAGNETIC TOMOGRAPHY .2. EFFECTS OF NOOTROPIC THERAPY IN AGE-ASSOCIATED MEMORY IMPAIRMENT

      Neuropsychobiology
    27. ANDERER P; PASCUALMARQUI RD; SEMLITSCH HV; SALETU B
      DIFFERENTIAL-EFFECTS OF NORMAL AGING ON SOURCES OF STANDARD N1, TARGET N1 AND TARGET P300 AUDITORY EVENT-RELATED BRAIN POTENTIALS REVEALED BY LOW-RESOLUTION ELECTROMAGNETIC TOMOGRAPHY (LORETA)

      Electroencephalography and clinical neurophysiology. Evoked potentials
    28. HOWORKA K; PUMPRLA J; ANDERER P; SALETU B; SCHABMANN A
      EEG-MAPPING - DECREASE OF VIGILANCE IN TYPE-1 DIABETIC-PATIENTS WITH HISTORY OF REPEATED SEVERE HYPOGLYCEMIA

      Diabetologia
    29. PUMPRLA J; HOWORKA K; ANDERER P; SALETU B; KRIEGER M; SCHABMANN A
      REDUCTION OF LOW-FREQUENCY BAND SPECTRAL POWER AND CENTROID FREQUENCYIN ANALYSIS OF HEART-RATE-VARIABILITY IN DIABETIC-PATIENTS WITH HYPOGLYCEMIA UNAWARENESS

      Diabetologia
    30. LOFFLER H; SALETU B; GRUBER D; LINZMAYER L; MANDL M; METKA M; HUBER J; ANDERER P
      QUALITY-OF-LIFE IN INSOMNIACS WITH A POSTMENOPAUSAL SYNDROME

      Quality of life research
    31. SALETU B; LOFFLER H; ANDERER P; DECKER K; GRUBER G; KLOSCH G; KIRCHEIS L; MANDL M; PARAPATICS S; TSCHIDA U; KATSCHNIG H
      QUALITY-OF-LIFE IN NONORGANIC AND ORGANIC SLEEP DISORDERS

      Quality of life research
    32. ZEITLHOFER J; GRUBER G; ANDERER P; ASENBAUM S; SCHIMICEK P; SALETU B
      TOPOGRAPHIC DISTRIBUTION OF SLEEP SPINDLES IN YOUNG HEALTHY-SUBJECTS

      Journal of sleep research
    33. SALETUZYHLARZ G; SALETU B; ANDERER P; BRANDSTATTER N; FREY R; GRUBER G; KLOSCH G; MANDL M; GRUNBERGER J; LINZMAYER L
      NONORGANIC INSOMNIA IN GENERALIZED ANXIETY DISORDER .1. CONTROLLED-STUDIES ON SLEEP, AWAKENING AND DAYTIME VIGILANCE UTILIZING POLYSOMNOGRAPHY AND EEG MAPPING

      Neuropsychobiology
    34. SALETU B; SALETUZYHLARZ G; ANDERER P; BRANDSTATTER N; FREY R; GRUBER G; KLOSCH G; MANDL M; GRUNBERGER J; LINZMAYER L
      NONORGANIC INSOMNIA IN GENERALIZED ANXIETY DISORDER .2. COMPARATIVE-STUDIES ON SLEEP, AWAKENING, DAYTIME VIGILANCE AND ANXIETY UNDER LORAZEPAM PLUS DIPHENHYDRAMINE (SOMNIUM(R)) VERSUS LORAZEPAM ALONE, UTILIZING CLINICAL, POLYSOMNOGRAPHIC AND EEG MAPPING METHODS

      Neuropsychobiology
    35. SCHMITZ M; FREY R; PICHLER P; ROPKE H; ANDERER P; SALETU B; RUDAS S
      SLEEP QUALITY DURING ALCOHOL-WITHDRAWAL WITH BRIGHT LIGHT THERAPY

      Progress in neuro-psychopharmacology & biological psychiatry
    36. DANTENDORFER K; MAIERHOFER D; DAUM I; SCHUGENS M; ANDERER P; SEMLITSCH HV; KATSCHNIG H
      CONDITIONAL DISCRIMINATION-LEARNING IN SCHIZOPHRENIA

      International journal of psychophysiology
    37. SALETU B; ANDERER P; SEMLITSCH HV
      RELATIONS BETWEEN SYMPTOMATOLOGY AND BRAIN-FUNCTION IN DEMENTIAS - DOUBLE-BLIND, PLACEBO-CONTROLLED, CLINICAL AND EEG ERP MAPPING STUDIES WITH NICERGOLINE/

      Dementia and geriatric cognitive disorders
    38. SEMLITSCH HV; SALETU B; ANDERER P; GRUNBERGER J; LINZMAYER L
      TESTING DRUGS FOR IMPAIRED BRAIN-FUNCTION IN OLD-AGE - ON THE EFFECTSOF A SINGLE-DOSE OF BIFEMELANE USING TOPOGRAPHIC MAPPING OF EEG AND EVENT-RELATED POTENTIALS (P300) AND PSYCHOMETRIC MEASUREMENTS IN HEALTHY ELDERLY SUBJECTS

      Human psychopharmacology
    39. SALETU B; GRUNBERGER J; ANDERER P; LINZMAYER L
      EFFECTS OF THE NOVEL NEUROPROTECTIVE AGENT, RILUZOLE, ON HUMAN BRAIN-FUNCTION AND BEHAVIOR .1. DOUBLE-BLIND, PLACEBO-CONTROLLED EEG MAPPINGAND PSYCHOMETRIC STUDIES UNDER NORMOXIA

      Methods and findings in experimental and clinical pharmacology
    40. SALETU B; GRUNBERGER J; ANDERER P; LINZMAYER L
      EFFECTS OF THE NOVEL NEUROPROTECTIVE AGENT, RILUZOLE, ON HUMAN BRAIN-FUNCTION AND BEHAVIOR .2. DOUBLE-BLIND, PLACEBO-CONTROLLED EEG MAPPINGAND PSYCHOMETRIC STUDIES UNDER HYPOXIA

      Methods and findings in experimental and clinical pharmacology
    41. SALETU B; BRANDSTATTER N; METKA M; STAMENKOVIC M; ANDERER P; SEMLITSCH HV; HEYTMANEK G; HUBER J; GRUNBERGER J; LINZMAYER L; KURZ C; DECKER K; BINDER G; KNOGLER W; KOLL B
      HORMONAL, SYNDROMAL AND EEG MAPPING STUDIES IN MENOPAUSAL SYNDROME PATIENTS WITH AND WITHOUT DEPRESSION AS COMPARED WITH CONTROLS

      Maturitas
    42. SALETU B; GRUNBERGER J; ANDERER P; LINZMAYER L; KONIG P
      ON THE CEREBRO-PROTECTIVE EFFECTS OF CAROVERINE, A CALCIUM-CHANNEL BLOCKER AND ANTIGLUTAMATERGIC DRUG - DOUBLE-BLIND, PLACEBO-CONTROLLED, EEG MAPPING AND PSYCHOMETRIC STUDIES UNDER HYPOXIA

      British journal of clinical pharmacology
    43. HOWORKA K; HEGER G; SCHABMANN A; ANDERER P; TRIBL G; ZEITLHOFER J
      SEVERE HYPOGLYCEMIA UNAWARENESS IS ASSOCIATED WITH AN EARLY DECREASE IN VIGILANCE DURING HYPOGLYCEMIA

      Psychoneuroendocrinology
    44. SALETU B; GRUNBERGER J; ANDERER P; LINZMAYER L; ZYHLARZ G
      COMPARATIVE PHARMACODYNAMIC STUDIES WITH THE NOVEL SEROTONIN UPTAKE-ENHANCING TIANEPTINE AND - INHIBITING FLUVOXAMINE UTILIZING EEG MAPPINGAND PSYCHOMETRY

      Journal of neural transmission
    45. SALETU B; KLOSCH G; GRUBER G; ANDERER P; UDOMRATN P; FREY R
      FIRST-NIGHT-EFFECTS ON GENERALIZED ANXIETY DISORDER (GAD)-BASED INSOMNIA - LABORATORY VERSUS HOME SLEEP RECORDINGS

      Sleep
    46. ANDERER P
      REPLY TO POLLACK,DAVID REVIEW CRITIQUE

      Journal of Japanese studies
    47. TRIBL G; HOWORKA K; HEGER G; ANDERER P; THOMA H; ZEITLHOFER J
      EEG TOPOGRAPHY DURING INSULIN-INDUCED HYPOGLYCEMIA IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS

      European neurology
    48. ANDERER P; SEMLITSCH HV; SALETU B
      MULTICHANNEL AUDITORY EVENT-RELATED BRAIN POTENTIALS - EFFECTS OF NORMAL AGING ON THE SCALP DISTRIBUTION OF N1, P2, N2 AND P300 LATENCIES AND AMPLITUDES

      Electroencephalography and clinical neurophysiology
    49. SEMLITSCH HV; ANDERER P; SALETU B
      COGNITIVE PSYCHOPHYSIOLOGY IN ANXIOLYTIC DRUG RESEARCH

      Biological psychiatry
    50. SALETU B; HITZENBERGER G; GRUNBERGER J; ANDERER P; ZYHLARZ G; LINZMAYER L; RAMEIS H
      DOUBLE-BLIND, PLACEBO-CONTROLLED, PHARMACOKINETIC AND PHARMACODYNAMICSTUDIES WITH 2 NEW FORMULATIONS OF PIRACETAM (INFUSION AND SYRUP) UNDER HYPOXIA IN MAN

      International journal of clinical pharmacology and therapeutics
    51. LANGER G; KARAZMAN R; NEUMARK J; SALETU B; SCHONBECK G; GRUNBERGER J; DITTRICH R; PETRICEK W; HOFFMANN P; LINZMAYER L; ANDERER P; STEINBERGER K
      ISOFLURANE NARCOTHERAPY IN DEPRESSIVE PATIENTS REFRACTORY TO CONVENTIONAL ANTIDEPRESSANT DRUG-TREATMENT - A DOUBLE-BLIND COMPARISON WITH ELECTROCONVULSIVE TREATMENT

      Neuropsychobiology
    52. SEMLITSCH HV; ANDERER P; SALETU B; BINDER GA; DECKER KA
      COGNITIVE PSYCHOPHYSIOLOGY IN NOOTROPIC DRUG RESEARCH - EFFECTS OF GINKGO-BILOBA ON EVENT-RELATED POTENTIALS (P300) IN AGE-ASSOCIATED MEMORY IMPAIRMENT

      Pharmacopsychiatry
    53. SEMLITSCH HV; ANDERER P; SALETU B
      ACUTE EFFECTS OF THE ANXIOLYTICS SURICLONE AND ALPRAZOLAM ON COGNITIVE INFORMATION-PROCESSING UTILIZING TOPOGRAPHIC MAPPING OF EVENT-RELATED BRAIN POTENTIALS (P300) IN HEALTHY-SUBJECTS

      European Journal of Clinical Pharmacology
    54. SALETU B; GRUNBERGER J; ANDERER P; LINZMAYER L; KONIG P
      ACUTE CENTRAL EFFECTS OF THE CALCIUM-CHANNEL BLOCKER AND ANTIGLUTAMATERGIC DRUG CAROVERINE - DOUBLE-BLIND, PLACEBO-CONTROLLED, EEG MAPPING AND PSYCHOMETRIC STUDIES AFTER INTRAVENOUS AND ORAL-ADMINISTRATION

      Arzneimittel-Forschung
    55. SALETU B; BRANDSTATTER N; METKA M; STAMENKOVIC M; ANDERER P; SEMLITSCH HV; HEYTMANEK G; HUBER J; GRUNBERGER J; LINZMAYER L; KURZ C; DECKER K; BINDER G; KNOGLER W; KOLL B
      DOUBLE-BLIND, PLACEBO-CONTROLLED, HORMONAL, SYNDROMAL AND EEG MAPPINGSTUDIES WITH TRANSDERMAL ESTRADIOL THERAPY IN MENOPAUSAL DEPRESSION

      Psychopharmacology
    56. SALETU B; PAULUS E; LINZMAYER L; ANDERER P; SEMLITSCH HV; GRUNBERGER J; WICKE L; NEUHOLD A; PODREKA I
      NICERGOLINE IN SENILE DEMENTIA OF ALZHEIMER-TYPE AND MULTI INFARCT DEMENTIA - A DOUBLE-BLIND, PLACEBO-CONTROLLED, CLINICAL AND EEG ERP MAPPING STUDY/

      Psychopharmacology
    57. BARBANOJ MJ; ANDERER P; ANTONIJOAN RM; TORRENT J; SALETU B; JANE F
      TOPOGRAPHIC PHARMACO-EEG MAPPING OF INCREASING DOSES OF BUSPIRONE ANDITS COMPARISON WITH DIAZEPAM

      Human psychopharmacology
    58. SALETU B; GRUNBERGER J; LINZMAYER L; SEMLITSCH HV; ANDERER P; CHWATAL K
      PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES WITH A NEW ANXIOLYTIC, SURICLONE, UTILIZING EEG MAPPING AND PSYCHOMETRY

      British journal of clinical pharmacology
    59. SALETU B; KUFFERLE B; GRUNBERGER J; FOLDES P; TOPITZ A; ANDERER P
      CLINICAL, EEG MAPPING AND PSYCHOMETRIC STUDIES IN NEGATIVE SCHIZOPHRENIA - COMPARATIVE TRIALS WITH AMISULPRIDE AND FLUPHENAZINE

      Neuropsychobiology
    60. SALETU B; ANDERER P; BRANDSTATTER N; FREY R; GRUNBERGER J; KLOSCH G; MANDL M; WETTER T; ZEITLHOFER J
      INSOMNIA IN GENERALIZED ANXIETY DISORDER - POLYSOMNOGRAPHIC, PSYCHOMETRIC AND CLINICAL INVESTIGATIONS BEFORE, DURING AND AFTER THERAPY WITHA LONG-HALF-LIFE VERSUS A SHORT-HALF-LIFE BENZODIAZEPINE (QUAZEPAM VERSUS TRIAZOLAM)

      Neuropsychobiology
    61. SALETU B; SCHULZ H; HERRMANN WM; ANDERER P; SHROTRIYA RC; VANBRABANT E
      BMS-181168 FOR PROTECTION OF THE HUMAN BRAIN AGAINST HYPOXIA - DOUBLE-BLIND, PLACEBO-CONTROLLED EEG MAPPING STUDIES

      Pharmacopsychiatry
    62. SALETU B; GRUNBERGER J; ANDERER P; LINZMAYER L; PAKESCH G; ZYHLARZ G
      EFFECT-KINETICS ON BRAIN PROTECTION OF 2 CODERGOCRINE-MESYLATE PREPARATIONS (ARAMEXE-RETARD(R) AND HYDERGINE(R)) BY EEG MAPPING AND PSYCHOMETRY UNDER HYPOXIA

      Archives of gerontology and geriatrics
    63. ANDERER P
      READING AGAINST CULTURE - IDEOLOGY AND NARRATIVE IN THE JAPANESE NOVEL - POLLACK,D

      Journal of Japanese studies
    64. ANDERER P
      COMPLICIT FICTIONS - THE SUBJECT IN MODERN JAPANESE PROSE NARRATIVE -FUJII,JA

      Journal of Japanese studies
    65. ANDERER P; SALETU B; KLOPPEL B; SEMLITSCH HV; WERNER H
      DISCRIMINATION BETWEEN DEMENTED PATIENTS AND NORMALS BASED ON TOPOGRAPHIC EEG SLOW-WAVE ACTIVITY - COMPARISON BETWEEN Z-STATISTICS, DISCRIMINANT-ANALYSIS AND ARTIFICIAL NEURAL-NETWORK CLASSIFIERS

      Electroencephalography and clinical neurophysiology
    66. HOWORKA K; HEGER G; PUMPRLA J; ANDERER P; ZEITLHOFER J; TRIBL G; THOMA H
      HYPOGLYCEMIA UNAWARENESS IS ASSOCIATED WITH AN EARLY DECREASE IN VIGILANCE DURING HYPOGLYCEMIA

      Diabetologia
    67. SCHIMICEK P; ZEITLHOFER J; ANDERER P; SALETU B
      AUTOMATIC SLEEP-SPINDLE DETECTION PROCEDURE - ASPECTS OF RELIABILITY AND VALIDITY

      Clinical EEG electroencephalography
    68. SALETU B; BRANDSTATTER N; ANDERER P; SEMLITSCH HV; BINDER G; DECKER K; METKA M; HUBER J; KNOGLER W
      NEUROPHYSIOLOGICAL INVESTIGATIONS IN MENOPAUSAL SYNDROME WITH AND WITHOUT DEPRESSION AND NORMAL CONTROLS - EEG AND EP MAPPING

      Neuropsychopharmacology
    69. BRANDSTATTER N; SALETU B; METKA M; GRUNBERGER J; LINZMAYER L; ANDERER P; STAMENKOVIC M; RESINGER E; HUBER J; KNOGLER W; ZYHLARZ G; PFERSMANN D
      CLINICAL, PSYCHOPATHOLOGICAL AND PSYCHOMETRIC STUDIES IN MENOPAUSAL SYNDROME PATIENTS WITH AND WITHOUT DEPRESSION AS COMPARED WITH NORMAL CONTROLS

      Neuropsychopharmacology
    70. SALETU B; BARBANOJ MJ; ANDERER P; SIEGHART W; GRUNBERGER J
      CLINICAL-PHARMACOLOGICAL STUDY WITH THE 2 ISOMERS (D-FENFLURAMINE, L-FENFLURAMINE) OF FENFLURAMINE AND ITS COMPARISON WITH CHLORPROMAZINE AND D-AMPHETAMINE - BLOOD-LEVELS, EEG MAPPING AND SAFETY EVALUATION

      Methods and findings in experimental and clinical pharmacology
    71. ANDERER P; BARBANOJ MJ; SALETU B; SEMLITSCH HV
      RESTRICTION TO A LIMITED SET OF EEG-TARGET VARIABLES MAY LEAD TO MISINTERPRETATION OF PHARMACO-EEG RESULTS

      Neuropsychobiology
    72. SALETU B; SALETU M; GRUNBERGER J; FREY R; ANDERER P; MADER R
      TREATMENT OF THE ALCOHOLIC ORGANIC BRAIN-SYNDROME - DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL, PSYCHOMETRIC AND ELECTROENCEPHALOGRAPHIC MAPPING STUDIES WITH MODAFINIL

      Neuropsychobiology
    73. SEMLITSCH HV; ANDERER P; SALETU B; BINDER GA; DECKER KA
      ACUTE EFFECTS OF THE NOVEL ANTIDEPRESSANT VENLAFAXINE ON COGNITIVE EVENT-RELATED POTENTIALS (P300), EYE BLINK RATE AND MOOD IN YOUNG HEALTHY-SUBJECTS

      International clinical psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 03:10:05